Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank92
3Y CAGR+218.1%
5Y CAGR+7.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+218.1%/yr
vs -39.5%/yr prior
5Y CAGR
+7.8%/yr
Recent acceleration
Acceleration
+257.6pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.62M | -10.1% |
| 2024 | $11.82M | +393.4% |
| 2023 | $2.40M | +626.1% |
| 2022 | $330000.00 | -46.6% |
| 2021 | $618000.00 | -91.5% |
| 2020 | $7.31M | +196.5% |
| 2019 | $-7.58M | -408.0% |
| 2018 | $2.46M | +293.5% |
| 2017 | $-1.27M | -180.1% |
| 2016 | $1.59M | - |